An innovative programme in Telangana and Andhra Pradesh will offer protocol-based non-invasive treatment pathways for patients with complex neuro, uro, and gastro conditions
 
Hyderabad-based CARE Hospitals has launched an AI-powered, non-invasive therapy programme in collaboration with JOGO Health.
 
Developed in the US by a Johnson & Johnson JLABS-incubated company, JOGO Health integrates patented wearable EMG sensors, artificial intelligence, and real-time biofeedback to stimulate neuroplasticity and aid patients in regaining lost muscle function. Clinically validated through research collaborations with Harvard Medical School and the Mayo Clinic, the technology is already in use at top medical centres across the US, Canada, and Asia.
 
Dr Nikhil Mathur, Group Chief of Medical Services, CARE Hospitals, emphasised the significance of this initiative, stating, “This collaboration with JOGO Health marks a significant advancement in patient care. By leveraging AI-powered therapy, we are introducing a revolutionary treatment option that is non-invasive, effective, and accessible to patients with chronic neurological, urological, and gastroenterological conditions.”
 
Biju Nair, Zonal COO, CARE Hospitals, added, “At CARE Hospitals, we are committed to bringing the latest medical innovations to our patients. The integration of JOGO Health’s AI-driven therapy into our treatment protocols represents a paradigm shift in rehabilitation and recovery, reducing dependency on invasive procedures and improving overall patient outcomes.”
 
Siva Nadarajah, Co-founder and President,JOGO Health, shared his enthusiasm for the collaboration, saying, “JOGO Health is proud to partner with CARE Hospitals to introduce this groundbreaking AI-powered therapy in India. With our clinically validated technology, we are confident that this programme will significantly enhance patient recovery and quality of life.”